Norepinephrine and cardiovascular responses to maximal exercise in Parkinson's disease on and off medication

Movement Disorders

Volumn 24, Issue 12, 2009, Pages 1773-1778

  DiFrancisco Donoghue, Joanne ^a   Elokda, Ahmed ^b   Lamberg, Eric M ^c   Bono, Nancy ^a,d   Werner, William G ^a,b  

^a Academic Health Care Center Old Westbury   (United States)

^b NYIT   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Autonomic cardiac abnormalities; Blood pressure; Exercise test; Heart rate; Levodopa; Peak VO2; Sympathetic nervous system

Indexed keywords

AMANTADINE; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; ENTACAPONE; LEVODOPA; NORADRENALIN; PERGOLIDE MESILATE; PRAMIPEXOLE; RASAGILINE; ROPINIROLE; SELEGILINE; TRIHEXYPHENIDYL;

ADULT; AGE; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; HEART RATE; HEIGHT; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; OXYGEN CONSUMPTION; PARKINSON DISEASE; PRIORITY JOURNAL; TREADMILL EXERCISE; WEIGHT;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CASE-CONTROL STUDIES; ELECTROCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; PARKINSON DISEASE; STATISTICS, NONPARAMETRIC;

EID: 70450046459     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22612     Document Type: Article

References (22)

1. Baatile J, Langbein WE, Weaver F, Maloney C, Jost MB. Effect of exercise on perceived quality of life of individuals with Parkinson's disease. J Rehabil Res Dev 2000;37:529-534. (Pubitemid 34118672)
2. Stanley RK, Protas EJ, Jankovic J. Exercise performance in those having Parkinson's disease and healthy normals. Med Sci Sports Exerc 1999;31:761-766. (Pubitemid 29262665)
3. Protas EJ, Stanley RK, Jankovic J, MacNeill B. Cardiovascular and metabolic responses to upper- and lower-extremity exercise in men with idiopathic Parkinson's disease. Phys Ther 1996;76:34-40. (Pubitemid 26046190)
4. Roitman JL, Herridge M. ACSM's resource manual for guidelines for exercise testing and prescription, 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
5. Werner WG, DiFrancisco-Donoghue J, Lamberg EM. Cardiovascular response to treadmill testing in Parkinson disease. J Neurol Phys Ther 2006;30:68-73.
6. Mazzeo RS, Marshall P. Influence of plasma catecholamines on the lactate threshold during graded exercise. J Appl Physiol 1989;67:1319-1322. (Pubitemid 19276377)
7. Schneider DA, McLellan TM, Gass GC. Plasma catecholamine and blood lactate responses to incremental arm and leg exercise. Med Sci Sports Exerc 2000;32:608-613. (Pubitemid 30158332)
8. Greiwe JS, Hickner RC, Shah SD, Cryer PE, Holloszy JO. Norepinephrine response to exercise at the same relative intensity before and after endurance exercise training. J Appl Physiol 1999;86:531-535. (Pubitemid 29075804)
9. Weltman A, Wood CM, Womack CJ, et al. Catecholamine and blood lactate responses to incremental rowing and running exercise. J Appl Physiol 1994;76:1144-1149. (Pubitemid 24099953)
10. Barbic F, Perego F, Canesi M, et al. Early abnormalities of vascular and cardiac autonomic control in Parkinson's disease without orthostatic hypotension. Hypertension 2007;49:120-126. (Pubitemid 46360350)
11. Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST. Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology 2002;58:1247-1255. (Pubitemid 34411870)
12. Haapaniemi TH, Kallio MA, Korpelainen JT, et al. Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease. J Neurol 2000;247:868-874.
13. Kujawa K, Leurgans S, Raman R, Blasucci L, Goetz CG. Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. Arch Neurol 2000;57:1461-1463. (Pubitemid 30769123)
14. McInnis KJ, Balady GJ. Comparison of submaximal exercise responses using the Bruce vs modified Bruce protocols. Med Sci Sports Exerc 1994;26:103-107.
15. McInnis KJ, Balady GJ, Weiner DA, Ryan TJ. Comparison of ischemic and physiologic responses during exercise tests in men using the standard and modified Bruce protocols. Am J Cardiol 1992;69:84-89.
16. Hoehn MM, Yahr MD. Parkinsonism - onset progression and mortality. Neurology 1967;17:427-442.
17. Hambrecht RP, Schuler GC, Muth T, et al. Greater diagnostic sensitivity of treadmill versus cycle exercise testing of asymptomatic men with coronary artery disease. Am J Cardiol 1992;70:141-146.
18. O'Suilleabhain P, Bullard J, Dewey RB. Proprioception in Parkinson's disease is acutely depressed by dopaminergic medications. J Neurol Neurosurg Psychiatry 2001;71:607-610. (Pubitemid 33010574)
19. Hughson RL, Green HJ, Sharratt MT. Gas exchange, blood lactate, and plasma catecholamines during incremental exercise in hypoxia and normoxia. J Appl Physiol 1995;79:1134-1141.
20. Fattor JA, Miller BF, Jacobs KA, Brooks GA. Catecholamine response is attenuated during moderate-intensity exercise in response to the "lactate clamp". Am J Physiol Endocrinol Metab 2005;288:E143-E147.
21. Stainsby WN, Sumners C, Andrew GM. Plasma catecholamines and their effect on blood lactate and muscle lactate output. J Appl Physiol 1984;57:321-325.
22. Mouradian MM, Juncos JL, Serrati C, Fabbrini G, Palmeri S, Chase TN. Exercise and the anti-Parkinsonian response to levodopa. Clin Neuropharmacol 1987;10:351-355.